Skip Navigation
Department of Psychological & Brain Sciences

Gallagher Lab

Clearing div

My research program is broadly based in the area of Systems Neuroscience using animal models (rats and mice) as well as studies in humans; an area of special emphasis is neurocognitive aging. Over the lifespan a genetically determined program of development, maturation and senescence interacts with a complex array of environmental experiences and exposures that make up the life history of the individual. I study the neurobiological basis for widely differing outcomes at older ages, cognitive impairment on the one hand and well-preserved cognitive function on the other, the latter sometimes referred to as 'successful aging'. I head a diverse team of researchers that study these neurobiological mechanisms in rats, mice and humans and lead a series of studies to test treatments in animals as well as a clinical trial in humans designed to improve memory function in older adults who suffer from memory problems such as patients with mild cognitive impairment who are at risk for Alzheimer's disease. My basic research has been supported for over 20 years by the National institute on Aging. My clinical research in humans is currently supported by a 'Grand Opportunity Award', a stimulus-funded research grant under American Recovery and Reinvestment Act of 2009. I also head the Neurogenetics and Behavior Center at Johns Hopkins University, an innovative resource to study mice with targeted genetic manipulations at high levels of cognitive/affective function, founded with funding by the National Center for Research Resources.


Upcoming Events:

Clinical Trials for Alzheimer's Disease (CTAD)

Michela Gallagher will speak on the clinical trial in MCI reducing hippocampal overactivity: HOPE4MCI on Saturday, November 7, 2015, in Barcelona, Spain.


Recent Press:

Slow Down!, Johns Hopkins University, Arts & Sciences Magazine, Fall 2015

Drug for early Alzheimer's heads to clinical trial, JHU HUB, September 2015

Clinical Trial Reveals Promising Brain Therapeutic Drug for the Pre-Dementia Stage of Alzheimer’s Disease, Alzheimer's News Today, March 18, 2015

A Drug Has Been Found That Reverses a Precursor to Alzheimer’s, TIME, March 12, 2015

Drug Restores Brain Function and Memory in Early Alzheimer’s Disease, Johns Hopkins University, March 11, 2015

A fine balance: Regulation of hippocampal Arc/Arg3.1 transcription, translation and degradation in a rat model of normal cognitive aging, Neurobiology Learn & Memory, November 2014

Proactive and reactive inhibitory control in rats, Frontiers in Neuroscience, May 2014

Age-associated changes in hippocampal-dependent cognition in Diversity Outbred mice, Hippocampus, June 2014

Society for Neuroscience 2014 Poster Presentations

Style DIV, please skip.

Style DIV, please skip.